Clinical Trial Update: Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating weekly carboplatin, paclitaxel, and cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12